Table 3.
n | TNF-a (mg/L) | sIL-2R (kU/L) | IL-8 (μg/L) | NK (%) | ||
Group III | 20 | 0.58±0.23 | 310.0±30.7 | 0.72±0.2 | 59.65±7.5 | |
Group I | Pre-T | 50 | 18.8±8.9b | 390.9±12.0b | 2.42±0.8b | 43.12±6.5b |
Post-T | 50 | 10.5±6.8a | 310.22±8.9a | 1.12±0.5a | 52.90±7.0a | |
Group II | Pre-T | 35 | 19.0±7.2b | 395.7±16.5b | 2.45±0.8b | 43.02±6.8b |
Post-T | 35 | 15.62±7.9 | 355.6±9.5 | 1.80±0.7 | 46.54±6.9 |
αPre-T: before treatment; Post-T: after treatment;
P<0.05 vs before treatment in the same group;
P<0.01 vs group III.